Stock Market Reviews

Read and share opinions on RAPT (RAPT Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• RAPT Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
  Nov 6, 2025
• RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
  Nov 4, 2025
• RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of Ozureprubart (RPT904) in Patients with Food Allergies
  Oct 27, 2025
• Wells Fargo Boosts RAPT Therapeutics (RAPT) PT to $48 on Promising Anti-IgE Drug Data
  Oct 26, 2025
• RAPT Therapeutics Announces Pricing of Public Offering of Common Stock
  Oct 22, 2025
• RAPT Therapeutics Announces Proposed Public Offering of Common Stock
  Oct 21, 2025
• Rapt Therapeutics, Outperforming 98% Of All Stocks, Rockets After Topping Roche
  Oct 20, 2025
• RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU)
  Oct 19, 2025
• RAPT Therapeutics Announces FDA Clearance of IND Application to Proceed to Phase 2b Trial of RPT904 in Food Allergy
  Sep 29, 2025
• Wall Street Analysts Think Rapt Therapeutics (RAPT) Could Surge 101.02%: Read This Before Placing a Bet
  Aug 18, 2025
• RAPT Therapeutics Reports Second Quarter 2025 Financial Results
  Aug 7, 2025
• Wall Street Analysts Believe Rapt Therapeutics (RAPT) Could Rally 122.22%: Here's is How to Trade
  Aug 1, 2025
• Rapt Therapeutics (RAPT) Upgraded to Strong Buy: Here's Why
  Jul 15, 2025
• Does Rapt Therapeutics (RAPT) Have the Potential to Rally 183.83% as Wall Street Analysts Expect?
  Jul 15, 2025
• New Strong Buy Stocks for July 15th
  Jul 15, 2025
• RAPT Therapeutics Names Two Industry Veterans to its Board of Directors
  Jun 23, 2025